Replies to post #154692 on Biotech Values

[zipjet]

PFE/BMY 60:40

On a sales basis and assuming $10B in sales (eventually) the attributed sales is more than 2x for BMY over PFE relative to current sales.

But then on an EV/EBITDA BMY is ~30% more expensive.

Figures quickly eyeballed from Yahoo and may be dated.

ij